Patent Yard Sign in
Expired Canadian patentCanada

Morphinan derivative and its pharmaceutical applications

CA 2105072 C · Owner: Kawai, Koji · Inventors: Endoh, Takashi; Kawamura, Kuniaki; Nagase, Hiroshi

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

There is disclosed morphinan derivative represented by the general formula (I) or its pharmacologically acceptable acid addition salt:, (see fig. I), ~ represents a single or double bond. R1 represents an alkyl group having 1-5 carbon atoms, a cycloalkylalkyl group having 4-7 carbon atoms, a cycloalkenylalkyl group having 5-7 carbon atoms, an aryl group having 6-12 carbon atoms an, aralkyl group having 7-13 carbon atoms an alkenyl group having, 4-7 carbon atoms an allyl group, a furan-2-ylalkyl group having 1-5 carbon atoms, or a thiophen-2-ylalkyl group having 1-5 carbon atoms. R2 represents a hydrogen atom a hydroxy, group, a nitro group, an alkanoyloxy group having 1-5 carbon atoms, an …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed January 22, 1993 and granted July 28, 1998. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 22, 2013.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 22, 2015.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 22, 1993
GrantedJuly 28, 1998
Term endedJanuary 22, 2013
Patent numberCA 2105072 C
Classification (IPC)C07D489/00 +2 more

Timeline

Timeline From CIPO dates

1994199619982000200220042006200820102012Application filedJan 22, 1993Patent grantedJuly 28, 1998Term endedJan 22, 2013

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.